96363002: Tetracosactide (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\...

\Pituitary hormone\Anterior pituitary hormone\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

\Polypeptide hormone\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Pituitary hormone\Anterior pituitary hormone\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

\Polypeptide hormone\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Polypeptide hormone\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Polypeptide hormone\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

\Biological substance\Polypeptide\Polypeptide hormone\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

\Body substance\Biochemical tumor marker\Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative\Tetracosactide

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

159482016 Cosyntropin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

159483014 Tetracosactide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

159484015 Tetracosactrin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

159485019 Tetracosactin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3484962012 Tetracosactide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tetracosactide	Is a	Adrenocorticotropic hormone	false	Inferred relationship	Some
Tetracosactide	Is a	Corticotropin preparation	false	Inferred relationship	Some
Tetracosactide	Is a	Corticotropic agent	false	Inferred relationship	Some
Tetracosactide	Is a	Synthetic hormone agent	false	Inferred relationship	Some
Tetracosactide	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Anterior pituitary hormone (disposition)	true	Inferred relationship	Some
Tetracosactide	Is a	Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cosyntropin preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tetracosactide	Inferred relationship	Some
Tetracosactrin adverse reaction	Causative agent (attribute)	True	Tetracosactide	Inferred relationship	Some	1
Allergy to tetracosactrin	Causative agent (attribute)	False	Tetracosactide	Inferred relationship	Some
Product containing tetracosactide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tetracosactide	Inferred relationship	Some	1
Tetracosactrin 250micrograms/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tetracosactide	Inferred relationship	Some
Tetracosactrin 1mg/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tetracosactide	Inferred relationship	Some
Cosyntropin 50mcg/mannitol 10mg injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tetracosactide	Inferred relationship	Some
Cosyntropin 25mcg/mannitol 10mg injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tetracosactide	Inferred relationship	Some
Tetracosactide acetate	Is a	False	Tetracosactide	Inferred relationship	Some
Allergy to tetracosactrin	Causative agent (attribute)	True	Tetracosactide	Inferred relationship	Some	1
Tetracosactide acetate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Tetracosactide	Inferred relationship	Some
Tetracosactide-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tetracosactide	Inferred relationship	Some	1
Tetracosactide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tetracosactide	Inferred relationship	Some	1
Tetracosactide only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Tetracosactide	Inferred relationship	Some	1
Tetracosactide (as tetracosactide acetate) 250 microgram/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Tetracosactide	Inferred relationship	Some	1

Reference Sets